News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML
Talha Badar/X
Mar 4, 2025, 10:55

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

Talha Badar, Hematology/Oncology specialist at Mayo Clinic, shared an article by Jing Lu, et al. on X:

“Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML.

Venetoclax plus decitabine NOT INFERIOR to intensive chemo in young fit AML.

VEN+DEC was well tolerated.”

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML.

Authors: Jing Lu, et al.

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

 

AML cancer chemotherapy decitabine fight against cancer Global fight against cancer Jing Lu Mayo Clinic OncoDaily Oncology Talha Badar venetoclax
Special Coverage
Science
Mar 4, 2025, 10:55
Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML
Blog
Mar 4, 2025, 10:53
Wafaa M Rashed: Childhood cancer remains severely underfunded and under-researched
Science
Mar 4, 2025, 10:49
Kevin Boehm: Multimodal histopathologic models stratify HR+ early breast cancer
Blog
Mar 4, 2025, 10:44
Friends of Cancer Research welcomed Monica Bertagnolli to their Board of Directors
Blog
Mar 4, 2025, 10:32
Jessica Whorton: Top 5 Wellness Tips for Cancer Support
Blog
Mar 4, 2025, 10:23
Sanjay Popat: Patrick Forde on ADC design and activity in NSCLC
Blog
Mar 4, 2025, 10:15
Arjun Khadilkar: 6 components that may be helpful for writing a good progress note
Science
Mar 4, 2025, 10:05
Myeloma Paper of the Day, March 4th, suggested by Robert Orlowski
Career
Mar 4, 2025, 09:57
David Rosenthal: I’m starting a new position as an Associate Professor at Yale School of Medicine
Blog
Mar 4, 2025, 09:54
Applications are open for the ASCO/AACR Methods in Clinical Cancer Research Workshop
Blog
Mar 4, 2025, 09:49
Muhammad Alsabagh: The prognostic value of CD79a in pediatric ALL
Blog
Mar 4, 2025, 09:42
Medicaid CF calls to stand against cancer